SI Shoulder Innovations, Inc.
USHealthcareAs of 2026-07-09 16:00
Why SI matters now
Shoulder Innovations, Inc. (SI) is a US stock in Healthcare. The latest InvestLog snapshot shows $21.23 with +4.58% on the session and $440.3M in market capitalization; recent performance reads 1-month +24.25% and YTD +29.72%.
The latest financial table shown here is Q1 2026, with revenue of $16.7M, net income of $-8.4M, and EPS of $-0.41. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -11.4%.
The latest indexable market news headline is "Shoulder Innovations Announces Closing of up to $50 Million Credit Facility" from PRNewsWire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $19.00; recent insider activity includes Ahearn Matthew Fraser filing S-Sale. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
2.88
P/S
7.14
EV/EBITDA
-9.44
DCF Value
$-150.70
FCF Yield
-11.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
75.5%
Operating Margin
-57.5%
Net Margin
-81.8%
ROE
-35.3%
ROA
-27.5%
ROIC
-20.9%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $16.7M | $-8.4M | $-0.41 |
| Q4 2025 | $14.4M | $-7.8M | $-0.38 |
| FY 2025 | $47.3M | $-40.4M | $-1.96 |
| Q3 2025 | $11.8M | $-8.7M | $-0.43 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$19.00
Target (Median)
$19.00
Target Range
$19.00 - $19.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Specialties
Country
US
Exchange
—
Beta
-1.07
Shoulder Innovations, Inc. is a medical technology firm that engineers and produces sophisticated devices. The company is particularly recognized for designing an innovative shoulder replacement system. Co-founded in 2009 by Stephen B. Gunther and Michael DeVries, its main corporate office is situated in Grand Rapids, Michigan.